-
-
-
-
-
-
-
Oragenics Completes Acquisition of Odyssey Health’s Neurological Assets
-
-
-
-
-
-
-
Oragenics (OGEN) Enters into Agreement with Lantern Bioworks for Replacement-Therapy Assets
-
-
-
-
-
-
-
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
-
-
-
-
-
-
-
Oragenics (OGEN) Increases Board Size; Appoints Kim Murphy to Board
-
-
-
-
-
-
-
Intrexon Announces Third Quarter 2016 Financial Results
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

